Wall Street Journal | Medical-Device Investment Rises in Second Quarter

Jul 2020

Brian Bock, Lincoln International Managing Director, discusses with the The Wall Street Journal how investments in the medical device sector have been impacted by the #COVID19 pandemic and the expectation that they should rise in the second half of the year.

View full article originally posted on July 30, 2020, by the Wall Street Journal here.

Summary

Contributor

Meet our Senior Team in Healthcare

Sound advice coupled with deep sector knowledge and international reach is how I add value and lead to successful outcomes for my clients.

Gunnar Brundin

Managing Director

Stockholm

Fatheazam Shahab
The healthcare market is ever-changing and increasingly complex and always puts one in touch with exceptional people of many talents.

Shahab Fatheazam

Vice Chairman | Healthcare

Chicago

Barry Freeman
I am a fierce, tireless advocate for my clients in securing world-class outcomes on their transactions.

Barry Freeman

Managing Director

Chicago

Honesty and integrity are very important to me. I have a genuine interest in learning about clients and their businesses, as well as pushing myself to continuously evolve in my role as a valued advisor.

Cynthya Goulet

Managing Director

Chicago

It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.

Matthew Lee

Managing Director

London

Dirk Loeffler
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.

Dirk-Oliver Löffler

Managing Director | European Co-head Healthcare

Frankfurt

Gaurav Marathe
The opportunity to advise accomplished business professionals and be part of their growth story and value creation is what keeps me inspired to work in this industry

Gaurav Marathe

Managing Director | CEO India

Mumbai

Roderick O'Niell
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.

Roderick O’Neill

Managing Director

New York

François Rispoli
I strive to be a trusted advisor to my clients, adding value throughout their journey, and helping them to reach successful outcomes.

François Rispoli

Managing Director

Paris

Derek Ritchea
I enjoy partnering with disruptive healthcare technology businesses and executives, providing support to achieve their long-term growth objectives in their pursuit to revolutionize the industry.

Derek Ritchea

Managing Director

New York

Siano Mike 616x616
It is exciting to be a part of the incredible transformation underway in the healthcare sector and I work passionately to help clients achieve exceptional results.

Michael Siano

Managing Director

New York

James West
I strive to build long-term relationships with key individuals in my sectors of focus in order to provide the best advisory services for my clients.

James West

Managing Director

London

View All

Related Perspectives

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More

View All Perspectives